Report cover image

Global Syndromic Multiplex Diagnostic Market - Industry Trends and Forecast to 2029

Publisher Data Bridge Market Research
Published Apr 01, 2022
Length 297 Pages
SKU # DAABD17338339

Description

Global Syndromic Multiplex Diagnostic Market - Industry Trends and Forecast to 2029

The global syndromic multiplex diagnostic market is projected to register a CAGR of 8.7% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2020, and the forecast period is 2022 to 2029

Market Segmentation

Global Syndromic Multiplex Diagnostic Market - By Product and Services (Reagents & Consumables, Instruments, Software & Accessories and Services), Infection type (Viral, Bacterial, Parasites and Fungal), Disease (Respiratory Infections, Gastroenteritis, Sexually Transmitted Infections, Sepsis, Meningitis and Others), Panels Type (Respiratory Panel, GI-Enteric Panel, SexuallyTransmitted Disease Panel, Blood-Sepsis Panel, Meningitis panel and Others), End User (Clinical Laboratories, Hospitals, Pharmaceutical & Biotechnology Companies, Research Institutes and Others), Country (U.S., Canada, Mexico, Germany, France ,U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippine, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) – Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of global syndromic multiplex diagnostic market are:
• Increase in prevalence of infectious diseases
• Growing technological advancement
• Increasing awareness towards early diagnosis
• Strategic initiatives

Market Players

The major companies which are dealing in the global syndromic multiplex diagnostic are listed below:
• BioFire Diagnostics (A Subsidiary of bioMérieux SA)
• Seegene Inc.
• Luminex Corporation. A DiaSorin Company
• F. Hoffmann-La Roche Ltd
• BD
• Bio-Rad Laboratories, Inc.
• Cepheid (A Subsidiary of Danaher)
• QIAGEN
• Abbott
• Hologic, Inc.
• Thermo Fisher Scientific Inc.
• Siemens Healthcare GmbH
• Akonni Biosystems, Inc.
• Biocartis
• QuantuMDx Group Ltd.
• Bosch Healthcare Solutions GmbH (A Subsidiary Of Robert Bosch GmbH)
• Applied BioCode, Inc.
• Prominex Inc.
• Nanōmix, Inc
• Curetis (A Subsidiary of OpGen, Inc.)
• MiRXES Pte Ltd.

Company Profiles

• BioFire Diagnostics (A Subsidiary of bioMérieux SA)
• Seegene Inc.
• Luminex Corporation. A DiaSorin Company
• F. Hoffmann-La Roche Ltd
• BD
• Bio-Rad Laboratories, Inc.
• Cepheid (A Subsidiary of Danaher)
• QIAGEN
• Abbott
• Hologic, Inc.
• Thermo Fisher Scientific Inc.
• Siemens Healthcare GmbH
• Akonni Biosystems, Inc.
• Biocartis
• QuantuMDx Group Ltd.
• Bosch Healthcare Solutions GmbH (A Subsidiary Of Robert Bosch GmbH)
• Applied BioCode, Inc.
• Prominex Inc.
• Nanōmix, Inc
• Curetis (A Subsidiary of OpGen, Inc.)
• MiRXES Pte Ltd.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

297 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Global Syndromic Multiplex Diagnostic Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Product And Services Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market End User Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter's Five Forces
4.3 Market Share Per Panel, For Top 3 Players (2021)
5 Global Syndromic Multiplex Diagnostic Market: Regulations
6 Market Overview
6.1 Drivers
6.1.1 Rising Prevalence Of Infectious Diseases
6.1.2 Rising Adoption Of Molecular Diagnostics Techniques
6.1.3 Increasing Regulatory Approval For Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-cov-2) Testing
6.1.4 Increasing Demand For Fast And Accurate Diagnostic Results
6.2 Restraints
6.2.1 High Cost Of Diagnostic Products
6.2.2 Explicit Limitation Of Syndromic Multiplex Diagnostic
6.3 Opportunities
6.3.1 Strategic Initiatives Taken By Market Players
6.3.2 Rising Diagnostic Healthcare Expenditure
6.3.3 Introduction Of Technological Advanced Products
6.4 Challenges
6.4.1 Product Recalls
6.4.2 Lack Of Skilled Professionals And Barriers Faced In Conducting Diagnostic Tests
7 Global Syndromic Multiplex Diagnostic Market, By Product & Services
7.1 Overview
7.2 Reagents & Consumables
7.3 Instruments, Software & Accessories
7.4 Services
8 Global Syndromic Multiplex Diagnostic Market, By Infection Type
8.1 Overview
8.2 Viral
8.2.1 Coronavirus
8.2.2 Influenza Virus
8.2.3 Adenovirus
8.2.4 Rhinovirus
8.2.5 Rotavirus
8.2.6 Others
8.3 Bacterial
8.3.1 Pneumoniae
8.3.2 Bordetella Pertussis
8.3.3 Staphylococcus
8.3.4 Others
8.4 Parasites
8.5 Fungal
9 Global Syndromic Multiplex Diagnostic Market, By Disease
9.1 Overview
9.2 Respiratory Infections
9.3 Gastroenteritis
9.4 Sexually Transmitted Infections
9.5 Sepsis
9.6 Meningitis
9.7 Others
10 Global Syndromic Multiplex Diagnostic Market, By Panels Type
10.1 Overview
10.2 Respiratory Panel
10.3 Gi-enteric Panel
10.4 Sexually Transmitted Disease Panel
10.5 Blood-sepsis Panel
10.6 Meningitis Panel
10.7 Others
11 Global Syndromic Multiplex Diagnostic Market, By End User
11.1 Overview
11.2 Hospitals
11.3 Clinical Laboratories
11.4 Pharmaceutical & Biotechnology Companies
11.5 Research Institutes
11.6 Others
12 Global Syndromic Multiplex Diagnostic Market, By Region
12.1 Overview
12.2 North America
12.2.1 U.S.
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 U.K.
12.3.3 France
12.3.4 Italy
12.3.5 Spain
12.3.6 Netherlands
12.3.7 Switzerland
12.3.8 Russia
12.3.9 Belgium
12.3.10 Turkey
12.3.11 Rest Of Europe
12.4 Asia-pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Australia
12.4.6 Singapore
12.4.7 Thailand
12.4.8 Malaysia
12.4.9 Indonesia
12.4.10 Philippines
12.4.11 Rest Of Asia-pacific
12.5 South America
12.5.1 Brazil
12.5.2 Argentina
12.5.3 Rest Of South America
12.6 Middle East And Africa
12.6.1 South Africa
12.6.2 Saudi Arabia
12.6.3 U.A.E
12.6.4 Israel
12.6.5 Egypt
12.6.6 Rest Of Middle East And Africa
13 Global Syndromic Multiplex Diagnostic Market: Company Landscape
13.1 Company Share Analysis: Global
13.2 Company Share Analysis: North America
13.3 Company Share Analysis: Europe
13.4 Company Share Analysis: Asia-pacific
14 Swot Analysis
15 Company Profile
15.1 Biofire Diagnostics (A Subsidiary Of Biomérieux Sa)
15.1.1 Company Snapshot
15.1.2 Revenue Analysis
15.1.3 Company Share Analysis
15.1.4 Product Portfolio
15.1.5 Recent Developments
15.2 F. Hoffmann-la Roche Ltd
15.2.1 Company Snapshot
15.2.2 Revenue Analysis
15.2.3 Company Share Analysis
15.2.4 Product Portfolio
15.2.5 Recent Development
15.3 Luminex Corporation. A Diasorin Company
15.3.1 Company Snapshot
15.3.2 Recent Financials
15.3.3 Company Share Analysis
15.3.4 Product Portfolio
15.3.5 Recent Development
15.4 Cepheid (A Subsidiary Of Danaher)
15.4.1 Company Snapshot
15.4.2 Recent Financials
15.4.3 Company Share Analysis
15.4.4 Product Portfolio
15.4.5 Recent Developments
15.5 Qiagen
15.5.1 Company Snapshot
15.5.2 Recent Financials
15.5.3 Company Share Analysis
15.5.4 Product Portfolio
15.5.5 Recent Development
15.6 Abbott
15.6.1 Company Snapshot
15.6.2 Revenue Analysis
15.6.3 Product Portfolio
15.6.4 Recent Development
15.7 Akonni Biosystems, Inc.
15.7.1 Company Snapshot
15.7.2 Product Portfolio
15.7.3 Recent Development
15.8 Applied Biocode, Inc.
15.8.1 Company Snapshot
15.8.2 Product Portfolio
15.8.3 Recent Developments
15.9 Bd
15.9.1 Company Snapshot
15.9.2 Revenue Analysis
15.9.3 Product Portfolio
15.9.4 Recent Developments
15.10 Biocartis
15.10.1 Company Snapshot
15.10.2 Revenue Analysis
15.10.3 Product Portfolio
15.10.4 Recent Development
15.11 Bio-rad Laboratories, Inc.
15.11.1 Company Snapshot
15.11.2 Revenue Analysis
15.11.3 Product Portfolio
15.11.4 Recent Development
15.12 Bosch Healthcare Solutions Gmbh (A Subsidiary Of Robert Bosch Gmbh)
15.12.1 Company Snapshot
15.12.2 Revenue Analysis
15.12.3 Product Portfolio
15.12.4 Recent Development
15.13 Curetis (A Subsidiary Of Opgen, Inc.)
15.13.1 Company Snapshot
15.13.2 Recent Financials
15.13.3 Product Portfolio
15.13.4 Recent Developments
15.14 Hologic, Inc.
15.14.1 Company Snapshot
15.14.2 Recent Financials
15.14.3 Product Portfolio
15.14.4 Recent Development
15.15 Mirxes Pte Ltd.
15.15.1 Company Snapshot
15.15.2 Product Portfolio
15.15.3 Recent Development
15.16 Nanōmix, Inc.
15.16.1 Company Snapshot
15.16.2 Product Portfolio
15.16.3 Recent Development
15.17 Prominex Inc.
15.17.1 Company Snapshot
15.17.2 Product Portfolio
15.17.3 Recent Development
15.18 Quantumdx Group Ltd.
15.18.1 Company Snapshot
15.18.2 Product Portfolio
15.18.3 Recent Developments
15.19 Seegene Inc.
15.19.1 Company Snapshot
15.19.2 Revenue Analysis
15.19.3 Product Portfolio
15.19.4 Recent Developments
15.20 Siemens Healthcare Gmbh
15.20.1 Company Snapshot
15.20.2 Recent Financials
15.20.3 Product Portfolio
15.20.4 Recent Development
15.21 Thermofisher Scientific Inc.
15.21.1 Company Snapshot
15.21.2 Recent Financials
15.21.3 Product Portfolio
15.21.4 Recent Development
16 Questionnaire
17 Related Reports
List Of Figures
Figure 1 Global Syndromic Multiplex Diagnostic Market: Segmentation
Figure 2 Global Syndromic Multiplex Diagnostic Market: Data Triangulation
Figure 3 Global Syndromic Multiplex Diagnostic Market: Droc Analysis
Figure 4 Global Syndromic Multiplex Diagnostic Market: Global Vs Regional Market Analysis
Figure 5 Global Syndromic Multiplex Diagnostic Market: Company Research Analysis
Figure 6 Global Syndromic Multiplex Diagnostic Market: Interview Demographics
Figure 7 Global Syndromic Multiplex Diagnostic Market: Dbmr Market Position Grid
Figure 8 Global Syndromic Multiplex Diagnostic Market: End User Coverage Grid
Figure 9 Global Syndromic Multiplex Diagnostic Market: Vendor Share Analysis
Figure 10 Global Syndromic Multiplex Diagnostic Market: Segmentation
Figure 11 Increasing Prevalence And Incidence Of Infectious Diseases Is Expected To Drive The Global Syndromic Multiplex Diagnostic Market In The Forecast Period
Figure 12 Reagents & Consumables Segment Is Expected To Account For The Largest Share Of The Global Syndromic Multiplex Diagnostic Market In 2022 & 2029
Figure 13 North America Is Expected To Dominate The Global Syndromic Multiplex Diagnostic Market And Asia-pacific Is Expected To Grow With The Highest Cagr In The Forecast Period
Figure 14 Asia-pacific Is The Fastest-growing Market For Global Syndromic Multiplex Diagnostic Market Manufacturers In The Forecast Period
Figure 15 Drivers, Restraints, Opportunities, And Challenges Of Global Syndromic Multiplex Diagnostic Market
Figure 16 Total Cases Of Covid-19 In North America
Figure 17 Total Cases Of Covid-19 In Europe
Figure 18 National Health Expenditure Vs Medical Device Expenditure, U.S., 2019
Figure 19 Global Syndromic Multiplex Diagnostic Market: By Product & Services, 2021
Figure 20 Global Syndromic Multiplex Diagnostic Market: By Product & Services, 2022-2029 (Usd Million)
Figure 21 Global Syndromic Multiplex Diagnostic Market: By Product & Services, Cagr (2022-2029)
Figure 22 Global Syndromic Multiplex Diagnostic Market: By Product & Services, Lifeline Curve
Figure 23 Global Syndromic Multiplex Diagnostic Market: By Infection Type, 2021
Figure 24 Global Syndromic Multiplex Diagnostic Market: By Infection Type, 2022-2029 (Usd Million)
Figure 25 Global Syndromic Multiplex Diagnostic Market: By Infection Type, Cagr (2022-2029)
Figure 26 Global Syndromic Multiplex Diagnostic Market: By Infection Type, Lifeline Curve
Figure 27 Global Syndromic Multiplex Diagnostic Market: By Disease, 2021
Figure 28 Global Syndromic Multiplex Diagnostic Market: By Disease, 2022-2029 (Usd Million)
Figure 29 Global Syndromic Multiplex Diagnostic Market: By Disease, Cagr (2022-2029)
Figure 30 Global Syndromic Multiplex Diagnostic Market: By Disease, Lifeline Curve
Figure 31 Global Syndromic Multiplex Diagnostic Market: By Panels Type, 2021
Figure 32 Global Syndromic Multiplex Diagnostic Market: By Panels Type, 2022-2029 (Usd Million)
Figure 33 Global Syndromic Multiplex Diagnostic Market: By Panels Type, Cagr (2022-2029)
Figure 34 Global Syndromic Multiplex Diagnostic Market: By Panels Type, Lifeline Curve
Figure 35 Global Syndromic Multiplex Diagnostic Market: By End User, 2021
Figure 36 Global Syndromic Multiplex Diagnostic Market: By End User, 2022-2029 (Usd Million)
Figure 37 Global Syndromic Multiplex Diagnostic Market: By End User, Cagr (2022-2029)
Figure 38 Global Syndromic Multiplex Diagnostic Market: By End User, Lifeline Curve
Figure 39 Global Syndromic Multiplex Diagnostic Market: Snapshot (2021)
Figure 40 Global Syndromic Multiplex Diagnostic Market: By Region (2021 )
Figure 41 Global Syndromic Multiplex Diagnostic Market: By Region (2022 & 2029)
Figure 42 Global Syndromic Multiplex Diagnostic Market: By Region (2021 & 2029)
Figure 43 Global Syndromic Multiplex Diagnostic Market: By Product And Services (2022-2029)
Figure 44 North America Syndromic Multiplex Diagnostic Market: Snapshot (2021)
Figure 45 North America Syndromic Multiplex Diagnostic Market: By Country (2021)
Figure 46 North America Syndromic Multiplex Diagnostic Market: By Country (2022 & 2029)
Figure 47 North America Syndromic Multiplex Diagnostic Market: By Country (2021 & 2029)
Figure 48 North America Syndromic Multiplex Diagnostic Market: By Product And Services (2022-2029)
Figure 49 Europe Syndromic Multiplex Diagnostic Market: Snapshot (2021)
Figure 50 Europe Syndromic Multiplex Diagnostic Market: By Country (2021)
Figure 51 Europe Syndromic Multiplex Diagnostic Market: By Country (2022 & 2029)
Figure 52 Europe Syndromic Multiplex Diagnostic Market: By Country (2021 & 2029)
Figure 53 Europe Syndromic Multiplex Diagnostic Market: By Product And Services (2022-2029)
Figure 54 Asia-pacific Syndromic Multiplex Diagnostic Market: Snapshot (2021)
Figure 55 Asia-pacific Syndromic Multiplex Diagnostic Market: By Country (2021)
Figure 56 Asia-pacific Syndromic Multiplex Diagnostic Market: By Country (2022 & 2029)
Figure 57 Asia-pacific Syndromic Multiplex Diagnostic Market: By Country (2021 & 2029)
Figure 58 Asia-pacific Syndromic Multiplex Diagnostic Market: By Product And Services (2022-2029)
Figure 59 South America Syndromic Multiplex Diagnostic Market: Snapshot (2021)
Figure 60 South America Syndromic Multiplex Diagnostic Market: By Country (2021 & 2029)
Figure 61 South America Syndromic Multiplex Diagnostic Market: By Country (2022 & 2029)
Figure 62 South America Syndromic Multiplex Diagnostic Market: By Country (2021 & 2029)
Figure 63 South America Syndromic Multiplex Diagnostic Market: By Product And Services (2022-2029)
Figure 64 Middle East And Africa Syndromic Multiplex Diagnostic Market: Snapshot (2021)
Figure 65 Middle East And Africa Syndromic Multiplex Diagnostic Market: By Country (2021)
Figure 66 Middle East And Africa Syndromic Multiplex Diagnostic Market: By Country (2022 & 2029)
Figure 67 Middle East And Africa Syndromic Multiplex Diagnostic Market: By Country (2021 & 2029)
Figure 68 Middle East And Africa Syndromic Multiplex Diagnostic Market: By Product And Services (2022-2029)
Figure 69 Global Syndromic Multiplex Diagnostic Market: Company Share 2021 (%)
Figure 70 North America Syndromic Multiplex Diagnostic Market: Company Share 2021 (%)
Figure 71 Europe Syndromic Multiplex Diagnostic Market: Company Share 2021 (%)
Figure 72 Asia-pacific Syndromic Multiplex Diagnostic Market: Company Share 2021 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us